Longevity Health (XAGE) shares almost doubled amid heavy trading after the company said late Monday that it will merge with THPlasma in a deal valued up to $79 million.
More than 98 million shares traded intraday compared with a daily average of about 512,000.
Kairos Pharma (KAPA) reported Tuesday positive safety results from an ongoing phase 2 trial of ENV-105 in advanced prostate cancer.
Shares surged 54% as intraday trading volume climbed to more than 226.8 million from a daily average of about 900,000.
Apple (AAPL) has signed a $500 million long-term agreement with MP Materials (MP), the latter said Tuesday.
Under the terms of the partnership, MP Materials will provide Apple with magnets produced at its Fort Worth, Texas, facility using recycled feedstock processed at its Mountain Pass site in California.
Shares of MP advanced 23% as intraday trading volume catapulted to more than 57.5 million from a daily average of about 11.5 million.
Price: 5.22, Change: +2.58, Percent Change: +97.35
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。